[Updated on Oct. 4] Integration of CiNii Articles into CiNii Research from April 1, 2022

Randomized, open label, phase III trial of figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin in patients with non-small cell lung cancer (NSCLC)

Journal

Related Articles

See more

Related Data

See more

Related Books

See more

Related Dissertations

See more

Related Projects

See more

Related Products

See more

Details

  • CRID
    1370851344065283585
  • Data Source
    • Crossref
Back to top